{"gene":"EIF2B3","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":1993,"finding":"GSK-3 phosphorylates the largest (epsilon) subunit of eIF-2B and is rapidly inactivated by insulin, linking insulin signalling to eIF-2B activation through GSK-3 inhibition.","method":"Mono-S chromatography of CHO cell extracts, immunoblotting with GSK-3 isoform-specific antibodies, peptide kinase assays, protein phosphatase-2A reversal experiments","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — reciprocal biochemical fractionation + immunoblotting + phosphatase reversal; replicated in subsequent studies","pmids":["8397507"],"is_preprint":false},{"year":1992,"finding":"Agents that disrupt ER calcium homeostasis (thapsigargin, A23187, DTT) cause phosphorylation of eIF-2α and a ~50% reduction in eIF-2B activity, inhibiting translational initiation; chronic exposure leads to recovery coincident with eIF-2α dephosphorylation.","method":"Intact GH3 cell treatment, eIF-2B activity assay, isoelectric focusing to measure eIF-2α phosphorylation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean cell-based assays with multiple agents and time-course; single lab","pmids":["1512215"],"is_preprint":false},{"year":1995,"finding":"In yeast, overexpression of all five subunits of eIF-2B suppresses eIF-2α hyperphosphorylation effects on general and GCN4-specific translation; phosphorylated eIF-2 acts as a competitive inhibitor of eIF-2B rather than forming an irreversibly inhibitory complex.","method":"Gene dosage experiments (overexpression and deletion of eIF-2B subunit genes in S. cerevisiae), GCN4-lacZ reporter assays, genetic epistasis","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple genetic manipulations and orthogonal reporter assays in yeast; strong preponderance of evidence","pmids":["7565788"],"is_preprint":false},{"year":1994,"finding":"eIF-2B is a heteropentamer (α, β, γ, δ, ε subunits) functioning as a guanine nucleotide exchange factor for eIF-2; it promotes release of GDP from eIF-2·GDP, enabling formation of active eIF-2·GTP. The ε subunit is catalytically essential, and phosphorylation of eIF-2α inhibits eIF-2B activity.","method":"Biochemical purification, guanine nucleotide exchange assays, review of cloning data and functional complementation studies","journal":"Biochimie","confidence":"High","confidence_rationale":"Tier 1–2 — synthesis of multiple in vitro reconstitution and genetic studies across labs","pmids":["7893825"],"is_preprint":false},{"year":2000,"finding":"EIF2Bγ (the gamma subunit of eIF2B) is required for HCV IRES-mediated translation; ribozymes targeting EIF2Bγ mRNA inhibit IRES-dependent translation of HCV core protein without affecting cap-dependent translation.","method":"Randomized hairpin ribozyme library selection in HeLa cells stably expressing bicistronic HCV IRES reporter, ganciclovir/hygromycin selection, functional validation with additional ribozymes","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — functional genomics selection with multiple ribozyme validations; single lab","pmids":["10900014"],"is_preprint":false},{"year":1996,"finding":"Glucose stimulates eIF-2B guanine nucleotide exchange activity in isolated rat islets of Langerhans within 15 min, over the same concentration range that stimulates insulin synthesis, via a mechanism independent of eIF-2α phosphorylation.","method":"eIF-2B activity assay in isolated rat islets, eIF-2α phosphorylation measured by isoelectric focusing/immunoblot, mannoheptulose as non-metabolizable control","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal assays in primary tissue; single lab","pmids":["8567668"],"is_preprint":false},{"year":1994,"finding":"Purified rat and bovine liver eIF-2B is a five-subunit complex (30.9–89.1 kDa); protein kinase activity in rat liver extracts phosphorylates only the ε subunit of eIF-2B. Quantitative immunoassay shows eIF-2B:eIF-2 ratios of ~0.6 (liver) and ~0.3 (reticulocytes).","method":"Biochemical purification to >95% homogeneity, monoclonal antibody generation, kinase assays with purified eIF-2B as substrate, quantitative immunoblotting","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 — direct biochemical purification with in vitro kinase assay and rigorous quantitation","pmids":["7803480"],"is_preprint":false},{"year":1994,"finding":"Mutations in the GCD7 (β) subunit of yeast eIF-2B overcome inhibition by phosphorylated eIF-2α without impairing catalytic GEF function, demonstrating that GCD7/eIF2Bβ plays a key role in the regulatory interaction between phospho-eIF-2 and eIF-2B.","method":"Suppressor mutation screen in S. cerevisiae, GCN4-lacZ reporter assays, growth assays under amino acid starvation and with constitutively active GCN2c kinase, expression of mammalian dsRNA-PK","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with multiple alleles and orthogonal functional tests; strong evidence","pmids":["8164676"],"is_preprint":false},{"year":1994,"finding":"Anti-ε monoclonal antibody inhibits eIF-2B guanine nucleotide exchange activity and protein synthesis at the initiation level in reticulocyte lysate; anti-β and anti-δ antibodies do not, establishing the ε subunit as essential for catalytic GEF activity.","method":"Monoclonal antibody inhibition assays of eIF-2B GEF activity and reticulocyte lysate translation, Western blotting, ELISA, immunoprecipitation","journal":"European journal of biochemistry","confidence":"High","confidence_rationale":"Tier 1 — direct inhibition of purified activity with subunit-specific antibodies; clean functional distinction","pmids":["8168527"],"is_preprint":false},{"year":1994,"finding":"Phosphorylation of eIF-2α at Ser-51 by HRI kinase inhibits eIF-2B GEF activity; Ser-48 in eIF-2α maintains high affinity between phospho-eIF-2 and eIF-2B, thereby inactivating eIF-2B. Expression of 51A mutant eIF-2α protects eIF-2B from inhibition.","method":"Overexpression of wild-type and mutant eIF-2α (S48A, S51A) in CHO cells, addition of purified HRI kinase to cell extracts, eIF-2B GEF activity assays, heat-shock experiments","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro kinase assays combined with cell-based overexpression and mutagenesis; multiple conditions","pmids":["8007958"],"is_preprint":false},{"year":2002,"finding":"GSK-3 phosphorylates eIF2Bε at Ser-535 in vivo; dephosphorylation of Ser-535 alone is insufficient for insulin-mediated activation of eIF2B, indicating additional regulatory inputs are required beyond GSK-3 inactivation.","method":"Site-specific phosphorylation analysis, GSK-3 inhibitors (LiCl, SB-415286, SB-216763) in CHO cells, eIF2B activity assays, phospho-specific antibodies","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 2 — multiple GSK-3 inhibitors with matched phosphorylation and activity measurements; strong evidence","pmids":["12133000"],"is_preprint":false},{"year":2000,"finding":"EGF- and NGF-induced activation of eIF2B in PC12 cells requires MEK/ERK signalling (blocked by PD98059), and this occurs without detectable dephosphorylation of the GSK-3 site Ser-535 in eIF2Bε, revealing a GSK-3-independent activation pathway.","method":"PC12 cell treatment with EGF/NGF ± MEK inhibitor PD98059, eIF2B activity assays, phospho-Ser535 immunoblotting, GSK-3 activity measurement","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibition with matched activity and phosphorylation readouts; single lab","pmids":["10913625"],"is_preprint":false},{"year":1987,"finding":"Phosphorylation of eIF-2α prevents eIF-2B-mediated dissociation of eIF-2·GDP from the 60S ribosomal subunit of complete initiation complexes, causing accumulation of eIF-2 on polysomes and a shift from 43S to 48S pre-initiation complexes; exogenous eIF-2B reverses these effects.","method":"Rabbit reticulocyte lysate sedimentation analysis, polysome profiling, Met-tRNA binding assays, addition of exogenous purified eIF-2B","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution with purified eIF-2B, multiple sedimentation and binding assays; mechanistically detailed","pmids":["3646234"],"is_preprint":false},{"year":1988,"finding":"Sugar phosphates (glucose 6-phosphate, fructose 1,6-diphosphate) are required for eIF-2B activity by a mechanism independent of eIF-2α phosphorylation, suggesting a direct allosteric effect of sugar phosphates on eIF-2B function.","method":"Gel-filtered reticulocyte lysate translation assays, eIF-2B GDP dissociation assays, antibody neutralization of HCR kinase, isoelectric focusing for eIF-2α phosphorylation","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal approaches in cell-free system; single lab","pmids":["2842334"],"is_preprint":false},{"year":1984,"finding":"When eIF-2 is complexed with eIF-2B, dephosphorylation of eIF-2α is inhibited 75% and phosphorylation of eIF-2β cannot be detected, whereas Met-tRNAi·GTP ternary complex formation specifically protects eIF-2β from dephosphorylation; these results show that eIF-2B and Met-tRNAi regulate accessibility of eIF-2 phosphorylation/dephosphorylation sites.","method":"Addition of doubly phosphorylated eIF-2 to reticulocyte lysate and purified phosphatase, kinase assays on eIF-2·eIF-2B complex, ternary complex formation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 1 — direct in vitro reconstitution with purified components; single lab","pmids":["6088496"],"is_preprint":false},{"year":1991,"finding":"eIF-2B-catalyzed conversion of eIF-2·GDP to eIF-2·GTP requires Met-tRNAi(fMet) (not tRNAi alone) for efficient GDP-to-GTP exchange; without Met-tRNAi, eIF-2B can dissociate GDP but cannot efficiently drive formation of the eIF-2·GTP complex.","method":"In vitro guanine nucleotide exchange assays with purified eIF-2 and eIF-2B, [3H]GDP release assays, ternary complex reconstitution","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 — direct in vitro reconstitution with purified components; single lab","pmids":["1764100"],"is_preprint":false},{"year":1995,"finding":"eIF-2B from calf brain is a five-subunit GEF complex (82, 65, 52, 42, 30 kDa) whose exchange activity is inhibited by N-ethylmaleimide; a 37-kDa calmodulin-binding protein co-purifies with the initiation factors from brain.","method":"Biochemical purification from brain (heparin-Sepharose, SP-5PW, DEAE-5PW HPLC), GEF activity assays, ternary complex assays, NEM inhibition","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 1 — direct biochemical purification and activity characterization; single tissue/lab","pmids":["7616232"],"is_preprint":false},{"year":2012,"finding":"The pyrophosphorylase-like domains (PLDs) and left-handed β-helix (LβH) domains of eIF2Bγ and eIF2Bε mediate extensive intersubunit interactions required for eIF2Bγ–ε subcomplex formation and overall eIF2B complex assembly; a potential nucleotide-binding region in the eIF2Bε PLD does not significantly contribute to nucleotide exchange catalysis.","method":"Co-expression and co-precipitation of domain constructs in yeast, genetic interaction analysis, domain deletion series","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — systematic domain mapping with co-precipitation and genetic approaches; single lab","pmids":["22238343"],"is_preprint":false},{"year":1995,"finding":"The rat eIF-2Bα subunit cDNA encodes a 305 aa protein with 42% identity to yeast GCN3; it functionally complements a gcn3 deletion in yeast for GCN4-dependent gene induction, establishing GCN3 as the yeast ortholog of mammalian eIF-2Bα.","method":"cDNA cloning from rat brain library, in vitro expression, Northern blotting, functional complementation of gcn3-null yeast","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — functional cross-species complementation plus sequence and expression validation","pmids":["7753796"],"is_preprint":false},{"year":2015,"finding":"VWM-associated mutations in eIF2Bα cause diverse biochemical defects including loss of binding to the eIF2B complex, reduction of GEF activity, or (unexpectedly) increased GEF activity, demonstrating that eIF2Bα participates in both structural integrity and regulatory modulation of the eIF2B complex.","method":"Overexpression of mutant eIF2Bα in HEK293 cells, affinity chromatography, co-immunoprecipitation of complex subunits, GEF activity assays","journal":"BMC medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple mutations tested with co-IP and activity assays; single lab","pmids":["26285592"],"is_preprint":false},{"year":2021,"finding":"CRISPR-generated zebrafish eif2b3 loss-of-function mutants display defects in myelin development, glial cell differentiation, increased integrated stress response gene expression, and ectopic VEGF-driven angiogenesis; VEGF receptor inhibition reduces ectopic angiogenesis, providing a VWM disease model and validating 19 human EIF2B3 disease variants.","method":"CRISPR mutagenesis in zebrafish, histology/immunostaining of myelin and glia, gene expression analysis, in silico protein modeling, VEGF receptor inhibitor treatment (SU5416), validation of human variants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — CRISPR knockout with multiple cellular phenotype readouts plus pharmacological rescue; strong vertebrate model","pmids":["33517449"],"is_preprint":false},{"year":2015,"finding":"Oligodendrocytes transfected with mutant EIF2B3 (c.1037T>C) show decreased tolerance to ER stress, depressed autophagy flux (reduced Atg3 and Atg7 expression), and increased apoptosis; autophagy inducers restore viability, while autophagy inhibitors worsen apoptosis, placing EIF2B3 mutation in a pathway connecting ER stress to autophagic dysfunction.","method":"Oligodendrocyte transfection with EIF2B3 mutant vs. wild-type, cell viability and apoptosis assays, autophagy flux measurement, Atg gene expression analysis, autophagy modulator treatments","journal":"Brain & development","confidence":"Medium","confidence_rationale":"Tier 2–3 — multiple cell-based assays with pharmacological rescue; single lab","pmids":["26625702"],"is_preprint":false},{"year":2015,"finding":"ISRIB reverses ISR attenuation by targeting an interaction between eIF2 and eIF2B; clustered missense mutations at the amino-terminal portion of the eIF2Bδ subunit (introduced by CRISPR-Cas9) reverse both ISRIB-mediated ISR inhibition and its stimulatory effect on eIF2B GEF activity in vitro.","method":"Somatic mutation screen, CRISPR-Cas9 knock-in of mutations, eIF2B GEF activity assays in vitro, ISR reporter cell assays","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1–2 — CRISPR knock-in mutagenesis combined with in vitro GEF activity reconstitution; replicated by structural studies","pmids":["25858979"],"is_preprint":false},{"year":2018,"finding":"Cryo-EM structure of human eIF2B at 4.1 Å resolution reveals ISRIB bound at the interface between the β and δ regulatory subunits; mutagenesis of residues lining this pocket alters ISRIB binding and the cellular ISR response, identifying a regulatory site that controls eIF2B activity.","method":"Cryo-electron microscopy (4.1 Å), site-directed mutagenesis of the ISRIB binding pocket, ISRIB binding assays in vitro, cellular ISR reporter assays","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM structure with mutagenesis validation; replicated by independent structural study","pmids":["29599245"],"is_preprint":false},{"year":2018,"finding":"Atomic-resolution cryo-EM structure of human eIF2B shows it forms a decameric holoenzyme (two tetrameric subcomplexes); ISRIB binds in a deep central cleft and promotes assembly of the decamer by cross-bridging a central symmetry interface, thereby enhancing GEF activity.","method":"Cryo-electron microscopy (atomic resolution), biochemical reconstitution of decameric complex, ISRIB binding assays, assembly-state analysis","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 1 — atomic-resolution structure with biochemical validation of assembly mechanism; independent corroboration from second cryo-EM study","pmids":["29599213"],"is_preprint":false},{"year":2002,"finding":"Mutations in EIF2B3 (encoding the γ subunit of eIF2B) cause leukoencephalopathy with vanishing white matter disease, demonstrating that all five eIF2B subunit genes can independently cause VWM.","method":"Mutation analysis/sequencing of EIF2B1-5 genes in VWM patients with previously unresolved genotype","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 3 — disease-gene identification by sequencing; establishes EIF2B3 as causative for VWM","pmids":["11835386"],"is_preprint":false},{"year":2012,"finding":"siRNA knockdown of eIF2Bγ in HCV-infected Huh7 cells inhibits HCV replication and core protein expression; combined knockdown of eIF2Bγ with IRES-specific siRNA produces stronger inhibition than either alone, confirming eIF2Bγ as an HCV co-factor in vivo.","method":"siRNA transfection in Huh7-HCV cells, fluorescence quantitative PCR, Western blotting for core protein","journal":"Zhonghua gan zang bing za zhi","confidence":"Medium","confidence_rationale":"Tier 2–3 — RNAi knockdown with matched mRNA and protein readouts; single lab","pmids":["23207339"],"is_preprint":false}],"current_model":"EIF2B3 encodes the γ subunit of eIF2B, a heterodecameric guanine nucleotide exchange factor (GEF) for eIF2 that is essential for translation initiation; its γ and ε subunits share pyrophosphorylase-like and left-handed β-helix domains that mediate intersubunit interactions, the ε subunit carries the catalytic GEF activity and is phosphorylated/inhibited by GSK-3 at Ser-535 (activated by insulin through GSK-3 inactivation), eIF2α phosphorylation inhibits eIF2B by converting eIF2 into a competitive inhibitor that traps eIF2B in an inactive complex, ISRIB activates eIF2B by binding at the β–δ subunit interface to promote decameric holoenzyme assembly, and EIF2B3 loss-of-function mutations cause vanishing white matter disease through defective myelination, impaired stress responses, and dysregulated autophagy in oligodendrocytes."},"narrative":{"teleology":[{"year":1984,"claim":"Early reconstitution showed that eIF-2B binding shields eIF-2 phosphorylation sites, establishing that the eIF-2·eIF-2B interaction is structurally intimate enough to alter substrate accessibility for kinases and phosphatases.","evidence":"In vitro addition of purified eIF-2B to phosphorylated eIF-2 in reticulocyte lysate with kinase/phosphatase assays","pmids":["6088496"],"confidence":"Medium","gaps":["Stoichiometry and binding interface unknown at this stage","Physiological relevance of shielding not tested in cells"]},{"year":1987,"claim":"Polysome profiling revealed that phospho-eIF-2α blocks eIF-2B-mediated GDP release from eIF-2 on ribosomes, trapping initiation complexes — this defined the mechanistic step at which translational inhibition occurs.","evidence":"Sedimentation analysis and Met-tRNA binding assays in reticulocyte lysate with purified eIF-2B add-back","pmids":["3646234"],"confidence":"High","gaps":["Identity and contribution of individual eIF-2B subunits not resolved","No structural information on the eIF-2·eIF-2B interface"]},{"year":1992,"claim":"ER-stress agents were shown to inhibit eIF-2B activity via eIF-2α phosphorylation, extending the regulatory paradigm from heme deficiency to a broader integrated stress response.","evidence":"Thapsigargin/A23187/DTT treatment of GH3 cells with eIF-2B activity and eIF-2α phosphorylation measurements","pmids":["1512215"],"confidence":"Medium","gaps":["Kinase identity mediating ER-stress-induced eIF-2α phosphorylation not identified","Mechanism of chronic recovery unclear"]},{"year":1993,"claim":"Identification of GSK-3 as the kinase phosphorylating the ε subunit of eIF-2B linked insulin signalling to translational control: insulin inactivates GSK-3, relieving inhibitory phosphorylation of eIF-2Bε.","evidence":"Mono-S chromatography fractionation of CHO extracts, GSK-3 isoform-specific immunoblotting, phosphatase-2A reversal","pmids":["8397507"],"confidence":"High","gaps":["GSK-3 target site on ε not yet mapped","Whether GSK-3 inhibition alone is sufficient for full activation unknown"]},{"year":1994,"claim":"Biochemical purification established eIF-2B as a five-subunit (α–ε) GEF, and antibody inhibition experiments demonstrated that the ε subunit is the catalytically essential GEF subunit, while β and δ are dispensable for catalysis per se.","evidence":"Purification to homogeneity from liver, subunit-specific monoclonal antibody inhibition of GEF activity and reticulocyte lysate translation","pmids":["7803480","8168527","7893825"],"confidence":"High","gaps":["Functions of non-catalytic subunits (including γ) not defined","No atomic structure"]},{"year":1994,"claim":"Yeast genetics showed that eIF2Bβ mutations uncouple phospho-eIF-2 sensing from catalytic function, establishing the regulatory subcompllex (α/β/δ) as a distinct functional module sensing eIF-2α phosphorylation.","evidence":"GCD7 suppressor mutations in S. cerevisiae with GCN4-lacZ reporter and mammalian kinase expression","pmids":["8164676","8007958"],"confidence":"High","gaps":["Molecular contacts between phospho-eIF-2α and the regulatory subcomplex unresolved","Role of γ subunit in regulation unclear"]},{"year":1995,"claim":"Overexpression of all five eIF-2B subunits in yeast demonstrated that phospho-eIF-2 acts as a competitive inhibitor rather than forming an irreversibly trapped complex, resolving a long-standing mechanistic debate.","evidence":"Gene dosage manipulation in S. cerevisiae with GCN4-lacZ reporters and genetic epistasis","pmids":["7565788"],"confidence":"High","gaps":["Quantitative binding parameters for phospho- vs. non-phospho-eIF-2 not determined"]},{"year":2000,"claim":"EIF2B3 (γ subunit) was identified as specifically required for HCV IRES-mediated translation but not cap-dependent translation, revealing a subunit-specific role beyond general GEF function.","evidence":"Randomized ribozyme library screen in HeLa cells with bicistronic HCV IRES reporter","pmids":["10900014"],"confidence":"Medium","gaps":["Mechanism by which γ depletion selectively affects IRES translation not elucidated","Confirmed only with ribozymes in one cell line"]},{"year":2002,"claim":"Two parallel advances: (1) GSK-3 phosphorylation of eIF2Bε was mapped to Ser-535, but dephosphorylation alone was shown insufficient for insulin-mediated activation, revealing additional regulatory inputs; (2) EIF2B3 mutations were found to cause vanishing white matter disease, establishing the γ subunit as independently disease-causative.","evidence":"GSK-3 inhibitors in CHO cells with phospho-specific antibodies; sequencing of EIF2B genes in VWM patients","pmids":["12133000","11835386"],"confidence":"High","gaps":["Identity of the additional insulin-responsive input unknown","Genotype–phenotype correlations for EIF2B3 mutations incomplete"]},{"year":2012,"claim":"Domain mapping showed that the pyrophosphorylase-like and left-handed β-helix domains of the γ and ε subunits mediate their association, defining the structural basis for the γ–ε subcomplex within the holoenzyme.","evidence":"Co-expression/co-precipitation of domain constructs in yeast with domain deletion series","pmids":["22238343"],"confidence":"Medium","gaps":["No atomic-resolution structure of the γ–ε interface","Functional consequences of disrupting specific domain contacts not fully tested in mammalian cells"]},{"year":2015,"claim":"ISRIB was shown to act by enhancing eIF2B GEF activity through a site on the β/δ regulatory subunits, and VWM-associated mutations in eIF2Bα and EIF2B3 were shown to impair ER stress tolerance and autophagy in oligodendrocytes, connecting eIF2B dysfunction to glial pathology.","evidence":"CRISPR knock-in mutagenesis with in vitro GEF assays for ISRIB; oligodendrocyte transfection with EIF2B3 mutant plus autophagy flux measurements","pmids":["25858979","26625702","26285592"],"confidence":"High","gaps":["Structural basis of ISRIB binding not yet resolved","Whether autophagy rescue is therapeutically relevant in vivo untested"]},{"year":2018,"claim":"Cryo-EM structures of the eIF2B decamer revealed that ISRIB binds a deep cleft at the β–δ symmetry interface and promotes decameric assembly, providing the atomic-level explanation for ISRIB pharmacology and illuminating the architecture of the holoenzyme including the γ subunit position.","evidence":"Cryo-EM at 4.1 Å and atomic resolution from two independent groups, with mutagenesis validation","pmids":["29599245","29599213"],"confidence":"High","gaps":["Structure of the eIF2B–eIF2 complex not resolved at this point","Conformational dynamics of substrate engagement by γ–ε catalytic lobe unknown"]},{"year":2021,"claim":"CRISPR-generated zebrafish eif2b3 knockouts recapitulated VWM hallmarks — myelin defects, glial differentiation failure, ISR activation, and ectopic VEGF-driven angiogenesis — and VEGF inhibition partially rescued the vascular phenotype, identifying a potential therapeutic axis.","evidence":"CRISPR mutagenesis in zebrafish with histology, gene expression profiling, and SU5416 pharmacological rescue","pmids":["33517449"],"confidence":"High","gaps":["Whether VEGF dysregulation is a direct or indirect consequence of eIF2B3 loss unknown","Translatability of VEGF inhibition to mammalian VWM models not tested"]},{"year":null,"claim":"Key unresolved questions include the specific structural contribution of the γ subunit to phospho-eIF2 sensing and GEF catalysis, the mechanism by which γ-subunit mutations selectively impair oligodendrocyte function, and whether γ-specific therapeutic strategies can complement ISRIB-like approaches for VWM.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of eIF2B–phospho-eIF2 complex with γ contacts mapped","Cell-type-specific vulnerability of oligodendrocytes to EIF2B3 mutations mechanistically unexplained","No therapeutic rescue of EIF2B3-specific mutations demonstrated in mammalian disease models"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[3,8,17,22,24]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3,6]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,12,15,24]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,10,11]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[1,9,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[20,25]}],"complexes":["eIF2B"],"partners":["EIF2B5","EIF2B2","EIF2B4","EIF2B1","EIF2S1"],"other_free_text":[]},"mechanistic_narrative":"EIF2B3 encodes the γ subunit of eIF2B, a heterodecameric guanine nucleotide exchange factor (GEF) that catalyzes GDP-to-GTP exchange on eIF2, a rate-limiting step in translation initiation [PMID:7893825, PMID:29599213]. The γ subunit contributes to holoenzyme assembly through its pyrophosphorylase-like and left-handed β-helix domains, which form extensive contacts with the catalytic ε subunit [PMID:22238343]; catalytic GEF activity resides in the ε subunit and is regulated by eIF2α phosphorylation (converting eIF2 into a competitive inhibitor of eIF2B), by GSK-3–mediated phosphorylation of ε Ser-535, and by ISRIB binding at the β–δ interface that promotes decameric assembly [PMID:7565788, PMID:8007958, PMID:25858979, PMID:29599245]. Loss-of-function mutations in EIF2B3 cause vanishing white matter disease (leukoencephalopathy), characterized by defective myelination, impaired integrated stress responses, and dysregulated autophagy in oligodendrocytes [PMID:11835386, PMID:33517449, PMID:26625702]."},"prefetch_data":{"uniprot":{"accession":"Q9NR50","full_name":"Translation initiation factor eIF2B subunit gamma","aliases":["eIF2B GDP-GTP exchange factor subunit gamma"],"length_aa":452,"mass_kda":50.2,"function":"Acts as a component of the translation initiation factor 2B (eIF2B) complex, which catalyzes the exchange of GDP for GTP on the eukaryotic initiation factor 2 (eIF2) complex gamma subunit (PubMed:25858979, PubMed:27023709, PubMed:31048492). Its guanine nucleotide exchange factor activity is repressed when bound to eIF2 complex phosphorylated on the alpha subunit, thereby limiting the amount of methionyl-initiator methionine tRNA available to the ribosome and consequently global translation is repressed (PubMed:25858979, PubMed:31048492)","subcellular_location":"Cytoplasm, cytosol","url":"https://www.uniprot.org/uniprotkb/Q9NR50/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/EIF2B3","classification":"Common Essential","n_dependent_lines":1204,"n_total_lines":1208,"dependency_fraction":0.9966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"EIF2S3","stoichiometry":10.0},{"gene":"EIF5","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/EIF2B3","total_profiled":1310},"omim":[{"mim_id":"620315","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 5; VWM5","url":"https://www.omim.org/entry/620315"},{"mim_id":"620314","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 4; VWM4","url":"https://www.omim.org/entry/620314"},{"mim_id":"620313","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 3; VWM3","url":"https://www.omim.org/entry/620313"},{"mim_id":"620312","title":"LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER 2; VWM2","url":"https://www.omim.org/entry/620312"},{"mim_id":"619701","title":"YOON-BELLEN NEURODEVELOPMENTAL SYNDROME; YOBELN","url":"https://www.omim.org/entry/619701"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/EIF2B3"},"hgnc":{"alias_symbol":["EIF2Bgamma","EIF-2B"],"prev_symbol":[]},"alphafold":{"accession":"Q9NR50","domains":[{"cath_id":"3.90.550.10","chopping":"4-147_154-240_294-323","consensus_level":"high","plddt":80.7047,"start":4,"end":323},{"cath_id":"2.160.10.10","chopping":"341-444","consensus_level":"high","plddt":83.6475,"start":341,"end":444}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR50","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR50-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9NR50-F1-predicted_aligned_error_v6.png","plddt_mean":72.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=EIF2B3","jax_strain_url":"https://www.jax.org/strain/search?query=EIF2B3"},"sequence":{"accession":"Q9NR50","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9NR50.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9NR50/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9NR50"}},"corpus_meta":[{"pmid":"8397507","id":"PMC_8397507","title":"Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B.","date":"1993","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/8397507","citation_count":349,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1512215","id":"PMC_1512215","title":"Phosphorylation of eukaryotic initiation factor (eIF) 2 alpha and inhibition of eIF-2B in GH3 pituitary cells by perturbants of early protein processing that induce GRP78.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1512215","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7565788","id":"PMC_7565788","title":"Modulation of tRNA(iMet), eIF-2, and eIF-2B expression shows that GCN4 translation is inversely coupled to the level of eIF-2.GTP.Met-tRNA(iMet) ternary complexes.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7565788","citation_count":112,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7893825","id":"PMC_7893825","title":"The guanine nucleotide-exchange factor, eIF-2B.","date":"1994","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/7893825","citation_count":89,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10900014","id":"PMC_10900014","title":"Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virus internal ribosome entry site-mediated translation using a functional genomics approach.","date":"2000","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10900014","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8567668","id":"PMC_8567668","title":"Glucose stimulates the activity of the guanine nucleotide-exchange factor eIF-2B in isolated rat islets of Langerhans.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8567668","citation_count":73,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7803480","id":"PMC_7803480","title":"Purification and characterization of eukaryotic translational initiation factor eIF-2B from liver.","date":"1994","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/7803480","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8164676","id":"PMC_8164676","title":"Mutations in the GCD7 subunit of yeast guanine nucleotide exchange factor eIF-2B overcome the inhibitory effects of phosphorylated eIF-2 on translation initiation.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8164676","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8168527","id":"PMC_8168527","title":"Use of monoclonal antibodies to study the structure and function of eukaryotic protein synthesis initiation factor eIF-2B.","date":"1994","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8168527","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8007958","id":"PMC_8007958","title":"Expression of mutant eukaryotic initiation factor 2 alpha subunit (eIF-2 alpha) reduces inhibition of guanine nucleotide exchange activity of eIF-2B mediated by eIF-2 alpha phosphorylation.","date":"1994","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/8007958","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12133000","id":"PMC_12133000","title":"Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.","date":"2002","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/12133000","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3646234","id":"PMC_3646234","title":"Evidence that phosphorylation of eIF-2(alpha) prevents the eIF-2B-mediated dissociation of eIF-2 X GDP from the 60 S subunit of complete initiation complexes.","date":"1987","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3646234","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2842334","id":"PMC_2842334","title":"Regulation of protein synthesis in rabbit reticulocyte lysate. Glucose 6-phosphate is required to maintain the activity of eukaryotic initiation factor (eIF)-2B by a mechanism that is independent of the phosphorylation of eIF-2 alpha.","date":"1988","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2842334","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22312164","id":"PMC_22312164","title":"Adult-onset vanishing white matter disease due to a novel EIF2B3 mutation.","date":"2012","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22312164","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6088496","id":"PMC_6088496","title":"The association of eIF-2 with Met-tRNAi or eIF-2B alters the specificity of eIF-2 phosphatase.","date":"1984","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/6088496","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10913625","id":"PMC_10913625","title":"The activation of eukaryotic initiation factor (eIF)2B by growth factors in PC12 cells requires MEK/ERK signalling.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/10913625","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23115207","id":"PMC_23115207","title":"A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation.","date":"2012","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23115207","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8368492","id":"PMC_8368492","title":"Preparation of a cell-free translation system with minimal loss of initiation factor eIF-2/eIF-2B activity.","date":"1993","source":"Analytical biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8368492","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7616232","id":"PMC_7616232","title":"Purification and characterization of guanine nucleotide-exchange factor, eIF-2B, and p37 calmodulin-binding protein from calf brain.","date":"1995","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7616232","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22238343","id":"PMC_22238343","title":"Identification of intersubunit domain interactions within eukaryotic initiation factor (eIF) 2B, the nucleotide exchange factor for translation initiation.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22238343","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26285592","id":"PMC_26285592","title":"Biochemical effects of mutations in the gene encoding the alpha subunit of eukaryotic initiation factor (eIF) 2B associated with Vanishing White Matter disease.","date":"2015","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26285592","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1764100","id":"PMC_1764100","title":"The conversion of eIF-2.GDP to eIF-2.GTP by eIF-2B requires Met-tRNA(fMet).","date":"1991","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/1764100","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33517449","id":"PMC_33517449","title":"Eif2b3 mutants recapitulate phenotypes of vanishing white matter disease and validate novel disease alleles in zebrafish.","date":"2021","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33517449","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3844338","id":"PMC_3844338","title":"Evaluation and significance of kinetic parameters governing function of protein synthesis initiation factors eIF-2 and eIF-2B.","date":"1985","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/3844338","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26625702","id":"PMC_26625702","title":"Endoplasmic reticulum stress intolerance in EIF2B3 mutant oligodendrocytes is modulated by depressed autophagy.","date":"2015","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/26625702","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3435553","id":"PMC_3435553","title":"Kinetic constants in the functioning of eIF-2 and eIF-2B.","date":"1987","source":"Biochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/3435553","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7753796","id":"PMC_7753796","title":"Molecular cloning and characterization of cDNA encoding the alpha subunit of the rat protein synthesis initiation factor eIF-2B.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7753796","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7802867","id":"PMC_7802867","title":"Protein synthesis in the developing rat liver: participation of initiation factors eIF-2 and eIF-2B.","date":"1994","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/7802867","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"6498200","id":"PMC_6498200","title":"Translation in micrococcal nuclease-treated cell-free extracts from Ehrlich ascites tumor cells. Stimulation by initiation factor eIF-2B.","date":"1984","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/6498200","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33687620","id":"PMC_33687620","title":"Identification of a Missense Variant in the EIF2B3 Gene Causing Vanishing White Matter Disease with Antenatal-Onset but Mild Symptoms and Long-Term Survival.","date":"2021","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/33687620","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7982969","id":"PMC_7982969","title":"The delta-subunit of murine guanine nucleotide exchange factor eIF-2B. Characterization of cDNAs predicts isoforms differing at the amino-terminal end.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7982969","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9345299","id":"PMC_9345299","title":"Catalysis of guanine nucleotide exchange on eIF-2 by eIF-2B: is it a sequential or substituted enzyme mechanism?","date":"1997","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9345299","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28597716","id":"PMC_28597716","title":"Postmortem Whole Exome Sequencing Identifies Novel EIF2B3 Mutation With Prenatal Phenotype in 2 Siblings.","date":"2017","source":"Journal of child neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28597716","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23124037","id":"PMC_23124037","title":"Identification of MRI1, encoding translation initiation factor eIF-2B subunit alpha/beta/delta-like protein, as a candidate locus for infantile epilepsy with severe cystic degeneration of the brain.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23124037","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9236156","id":"PMC_9236156","title":"The effects of pyrroloquinoline quinone on heme-regulated eIF-2alpha kinase and eIF-2B activities in eukaryotic protein synthesis.","date":"1997","source":"Blood cells, molecules & diseases","url":"https://pubmed.ncbi.nlm.nih.gov/9236156","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28904586","id":"PMC_28904586","title":"Case of Childhood Ataxia with Central Nervous System Hypomyelination with a Novel Mutation in EIF2B3 gene.","date":"2017","source":"Journal of pediatric neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/28904586","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3647910","id":"PMC_3647910","title":"eIF-2B and the exchange of guanine nucleotides bound to eIF-2.","date":"1987","source":"The International journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3647910","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34796993","id":"PMC_34796993","title":"A C-term truncated EIF2Bγ protein encoded by an intronically polyadenylated isoform introduces unfavorable EIF2Bγ-EIF2γ interactions.","date":"2021","source":"Proteins","url":"https://pubmed.ncbi.nlm.nih.gov/34796993","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31072091","id":"PMC_31072091","title":"Correlation Between Vanishing White Matter Disease and Novel Heterozygous EIF2B3 Variants Using Next-Generation Sequencing: A Case Report.","date":"2019","source":"Annals of rehabilitation medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31072091","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38872124","id":"PMC_38872124","title":"Adult-onset leukoencephalopathy with vanishing white matter with compound heterozygous EIF2B3 gene variants.","date":"2024","source":"BMC neurology","url":"https://pubmed.ncbi.nlm.nih.gov/38872124","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8103216","id":"PMC_8103216","title":"Purification of eukaryotic initiation factors eIF-2, eIF-2B and eIF-2 alpha kinase from bovine liver.","date":"1993","source":"Preparative biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8103216","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24028880","id":"PMC_24028880","title":"Childhood Ataxia with Cerebral Hypomyelination Syndrome: a Variant of Patient with Early Childhood Onset Related to EIF2B3 Mutation. A Case Report.","date":"2012","source":"The neuroradiology journal","url":"https://pubmed.ncbi.nlm.nih.gov/24028880","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23207339","id":"PMC_23207339","title":"[siRNAs targeting La, hVAP-33, eIF2Bgamma, and HCV IRES inhibit the replication and expression of HCV in Huh7 cells].","date":"2012","source":"Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/23207339","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7866313","id":"PMC_7866313","title":"Is there a need for channelling in the functioning of the protein synthesis initiation factors eIF-2 and eIF-2B?","date":"1994","source":"Biochemistry and molecular biology international","url":"https://pubmed.ncbi.nlm.nih.gov/7866313","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17353931","id":"PMC_17353931","title":"Large-scale mapping of human protein-protein interactions by mass spectrometry.","date":"2007","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/17353931","citation_count":733,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889549","id":"PMC_8889549","title":"Generation and analysis of 280,000 human expressed sequence tags.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889549","citation_count":376,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31006538","id":"PMC_31006538","title":"Intrinsically Disordered Protein TEX264 Mediates ER-phagy.","date":"2019","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/31006538","citation_count":296,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11835386","id":"PMC_11835386","title":"Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.","date":"2002","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/11835386","citation_count":293,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27173435","id":"PMC_27173435","title":"An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27173435","citation_count":211,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26673895","id":"PMC_26673895","title":"A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.","date":"2015","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26673895","citation_count":198,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25858979","id":"PMC_25858979","title":"Stress responses. Mutations in a translation initiation factor identify the target of a memory-enhancing compound.","date":"2015","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/25858979","citation_count":184,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32807901","id":"PMC_32807901","title":"UFMylation maintains tumour suppressor p53 stability by antagonizing its ubiquitination.","date":"2020","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/32807901","citation_count":168,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29599245","id":"PMC_29599245","title":"Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29599245","citation_count":161,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11230166","id":"PMC_11230166","title":"Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.","date":"2001","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11230166","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29599213","id":"PMC_29599213","title":"Structure of the nucleotide exchange factor eIF2B reveals mechanism of memory-enhancing molecule.","date":"2018","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/29599213","citation_count":147,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16710414","id":"PMC_16710414","title":"The DNA sequence and biological annotation of human chromosome 1.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16710414","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":21545,"output_tokens":5024,"usd":0.069998},"stage2":{"model":"claude-opus-4-6","input_tokens":8776,"output_tokens":3254,"usd":0.187845},"total_usd":0.557314,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":32927,"output_tokens":6461,"usd":0.097848},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":10638,"output_tokens":3249,"usd":0.201623}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GSK-3 phosphorylates the largest (epsilon) subunit of eIF-2B and inhibits its guanine nucleotide exchange activity; insulin rapidly inactivates GSK-3 (via phosphorylation of GSK-3), thereby relieving inhibition of eIF-2B.\",\n      \"method\": \"Chromatographic kinase fractionation, immunoblotting with GSK-3 isoform-specific antibodies, phosphatase-2A reversal, peptide substrate assays in CHO cells expressing the human insulin receptor\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal biochemical fractionation + immunoblot + phosphatase reversal; independently corroborated by multiple subsequent studies on GSK-3/eIF2Bε\",\n      \"pmids\": [\"8397507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Agents that deplete ER Ca2+ stores or cause ER stress (A23187, thapsigargin, DTT) increase eIF-2α phosphorylation ~5-fold and reduce eIF-2B activity ~50%, inhibiting translational initiation; prolonged exposure allows recovery coincident with eIF-2α dephosphorylation.\",\n      \"method\": \"Intact GH3 pituitary cell treatments, eIF-2B activity assay, isoelectric focusing to measure eIF-2α phosphorylation state\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean cell-based assays with pharmacological tools and phosphorylation readout; single lab\",\n      \"pmids\": [\"1512215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"In S. cerevisiae, overexpression of all five eIF-2B subunits suppresses the translation-inhibitory effects of eIF-2α hyperphosphorylation on both GCN4-specific and general translation; phosphorylated eIF-2 acts as a competitive inhibitor of eIF-2B rather than forming an irreversibly inactive complex.\",\n      \"method\": \"Genetic dosage experiments (overexpression of eIF-2B subunits), GCN4-lacZ reporter assays, growth assays under amino-acid starvation in S. cerevisiae\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal genetic manipulations (dosage of eIF-2, tRNA, eIF-2B) with quantitative in vivo translation readouts; replicated genetic framework\",\n      \"pmids\": [\"7565788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"eIF-2B is a heteropentamer (α, β, γ, δ, ε subunits) that catalyzes GDP→GTP exchange on eIF-2; phosphorylation of eIF-2α (Ser-51) causes inhibition of eIF-2B, and the epsilon subunit is the primary catalytic subunit (antibody to epsilon inhibits GEF activity and protein synthesis in reticulocyte lysate).\",\n      \"method\": \"Purification of eIF-2B from rabbit reticulocytes, monoclonal antibody generation, guanine nucleotide exchange assays, in vitro translation inhibition assays\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro GEF assay with subunit-specific inhibitory antibody; purified protein system\",\n      \"pmids\": [\"8168527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Mutations in the GCD7 (eIF-2Bβ) subunit of yeast eIF-2B render the complex insensitive to inhibition by phosphorylated eIF-2α without impairing essential GEF catalytic function, demonstrating that GCD7/β and GCD2/δ subunits mediate the regulatory interaction with phospho-eIF-2α.\",\n      \"method\": \"Suppressor genetics in S. cerevisiae, GCN4-lacZ reporter, growth assays with activated GCN2c or mammalian dsRNA-PK kinase expression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via suppressor screen plus multiple alleles and reporter assays; foundational yeast genetics paper\",\n      \"pmids\": [\"8164676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Phosphorylation of eIF-2α at Ser-51 directly inhibits eIF-2B guanine nucleotide exchange activity in vitro and in vivo; Ser-48 of eIF-2α maintains high-affinity interaction between phospho-eIF-2α and eIF-2B, further inactivating eIF-2B.\",\n      \"method\": \"Overexpression of wild-type and Ser48Ala/Ser51Ala eIF-2α mutants in CHO cells, addition of purified HRI kinase to cell extracts, eIF-2B GEF activity assay, heat-shock experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mutagenesis combined with purified kinase and in vitro GEF assay; mechanistic dissection of two regulatory serines\",\n      \"pmids\": [\"8007958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"eIF-2B was purified to homogeneity from rat and bovine liver as a five-subunit complex; protein kinase activity in liver extracts phosphorylates only the ε-subunit of eIF-2B, not any other subunit.\",\n      \"method\": \"Biochemical purification, SDS-PAGE, monoclonal antibody generation, in vitro kinase assays with purified eIF-2B as substrate\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay with purified substrate; single lab\",\n      \"pmids\": [\"7803480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Glucose activates eIF-2B in rat pancreatic islets within 15 min over the physiological concentration range (3–20 mM) through a mechanism independent of changes in eIF-2α phosphorylation, indicating a direct regulatory pathway for eIF-2B distinct from the eIF-2α phosphorylation mechanism.\",\n      \"method\": \"Isolated rat islets, eIF-2B GEF activity assay, isoelectric focusing for eIF-2α phosphorylation state, use of non-metabolizable glucose analogue\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assay with pharmacological controls and phosphorylation-state measurements; single lab\",\n      \"pmids\": [\"8567668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"EGF and NGF activate eIF-2B in PC12 cells via MEK/ERK signalling; inhibition of MEK by PD98059 blocks both eIF-2B activation and GSK-3 inactivation by these growth factors, but neither EGF nor NGF alter Ser535 phosphorylation on eIF-2Bε, indicating a regulatory mechanism distinct from the GSK-3/Ser535 pathway.\",\n      \"method\": \"PC12 cells, MEK inhibitor PD98059, eIF-2B activity assay, phospho-specific immunoblotting for Ser535 of eIF-2Bε and phospho-GSK-3\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pathway placement by pharmacological epistasis with direct activity and phosphorylation readouts; single lab\",\n      \"pmids\": [\"10913625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GSK-3 phosphorylates Ser535 on eIF-2Bε in vivo; insulin and serum cause dephosphorylation of Ser535 via PI3K-dependent inactivation of GSK-3. However, pharmacological inhibition of GSK-3 (LiCl, SB-415286, SB-216763) dephosphorylates Ser535 without activating eIF-2B, demonstrating that additional inputs beyond Ser535 dephosphorylation are required for insulin-mediated eIF-2B activation.\",\n      \"method\": \"CHO cells, GSK-3 inhibitors (LiCl, SB-415286, SB-216763), PI3K inhibitor, phospho-Ser535 immunoblotting, eIF-2B activity assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal GSK-3 inhibitors with direct phosphorylation and activity readouts; clear mechanistic dissection\",\n      \"pmids\": [\"12133000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"eIF-2Bγ (EIF2B3) was identified as a cellular cofactor required for hepatitis C virus IRES-mediated translation; ribozymes targeting eIF-2Bγ mRNA specifically inhibit HCV IRES-dependent translation of HCV core protein without affecting cap-dependent translation.\",\n      \"method\": \"Randomized hairpin ribozyme library selection in HeLa cells with bicistronic HCV IRES reporter, ganciclovir/hygromycin selection, validation with additional ribozymes against the same mRNA\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional genomics selection with independent validation ribozymes; single lab\",\n      \"pmids\": [\"10900014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The pyrophosphorylase-like domain (PLD) and left-handed β-helix domain of eIF-2Bγ (EIF2B3) are critical for intersubunit interactions within the eIF-2B complex; the eIF-2Bγ PLD does not play a significant role in nucleotide exchange catalysis, contrary to a previously proposed mechanism.\",\n      \"method\": \"Co-expression and co-precipitation of domain deletion/truncation constructs in yeast and mammalian cells; genetic analysis of putative nucleotide-binding residues in eIF-2Bε\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — co-precipitation with domain mapping and functional genetic assay; single lab\",\n      \"pmids\": [\"22238343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"Phosphorylation of eIF-2α prevents eIF-2B-mediated dissociation of eIF-2·GDP from the 60S ribosomal subunit of complete initiation complexes; exogenous eIF-2B reverses this by promoting dissociation of eIF-2·GDP from 80S and polysomal particles, enabling elongation.\",\n      \"method\": \"Rabbit reticulocyte lysate, sucrose gradient sedimentation, exogenous eIF-2B addition, measurement of Met-tRNAf binding to ribosomal subunits, half-mer polysome analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-free reconstitution with purified eIF-2B addition and quantitative ribosome fractionation; single lab\",\n      \"pmids\": [\"3646234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"eIF-2B protects the β-subunit phosphorylation site of eIF-2 from phosphatases while also inhibiting α-subunit dephosphorylation by ~75%; within the eIF-2·eIF-2B complex, kinase access to eIF-2α is reduced to ~30% and eIF-2β phosphorylation is virtually abolished, demonstrating that complex formation alters substrate accessibility for both kinases and phosphatases.\",\n      \"method\": \"Purified eIF-2 phosphorylated on α and β subunits added to reticulocyte lysate or purified phosphatase; ternary complex formation; eIF-2B addition; kinase assays measuring phosphorylation rates\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro assays with purified factors; single lab\",\n      \"pmids\": [\"6088496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"Efficient recycling of eIF-2·GDP to eIF-2·GTP by eIF-2B under physiological conditions requires Met-tRNAiMet (not tRNAiMet alone); the Met-tRNAiMet stabilizes the otherwise transient eIF-2·GTP complex, making the exchange reaction efficient in vitro.\",\n      \"method\": \"In vitro guanine nucleotide exchange assays with purified eIF-2B and eIF-2; [3H]GDP dissociation measured with and without Met-tRNAiMet or tRNAiMet\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified factors; single lab\",\n      \"pmids\": [\"1764100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Glucose-6-phosphate (and fructose-1,6-diphosphate) directly supports eIF-2B activity in reticulocyte lysate by a mechanism independent of eIF-2α phosphorylation state, suggesting sugar phosphates may be required for proper eIF-2B function.\",\n      \"method\": \"Sephadex-filtered reticulocyte lysate, GDP dissociation assay for eIF-2B activity, antibody to HRI, phosphatase treatment to remove eIF-2α phosphorylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional eIF-2B activity assay with pharmacological dissection; single lab, indirect mechanism\",\n      \"pmids\": [\"2842334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Several VWM-associated mutations in eIF-2Bγ (EIF2B3) reduce or abolish binding of the γ-subunit to the rest of the eIF-2B complex and decrease GEF activity; some mutations have unexpected effects including increased GEF activity, revealing roles of individual subunits in eIF-2B complex integrity.\",\n      \"method\": \"Overexpression of VWM mutant eIF-2B subunits in HEK293 cells, affinity chromatography, western blot assessment of complex formation and eIF-2 binding, GEF activity assay\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple VWM mutations tested with activity and complex-assembly readouts; single lab\",\n      \"pmids\": [\"26285592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Loss-of-function of zebrafish eif2b3 (ortholog of human EIF2B3) causes defects in myelin development, impaired glial cell differentiation, activation of the integrated stress response pathway, and ectopic angiogenesis with increased VEGF expression; ectopic angiogenesis was rescued by VEGF receptor inhibitor SU5416.\",\n      \"method\": \"CRISPR mutagenesis of zebrafish eif2b3, myelin and glial marker immunostaining, ISR pathway gene expression analysis, angiogenesis imaging, VEGF receptor inhibitor treatment\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR KO zebrafish with multiple orthogonal phenotypic readouts and pharmacological rescue; single lab\",\n      \"pmids\": [\"33517449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"EIF2B3 mutant oligodendrocytes show decreased tolerance to ER stress, with depressed autophagy flux (reduced Atg3 and Atg7) at baseline and after ER stress induction; autophagy inducers rescue cell viability and reduce apoptosis in mutant cells under ER stress, while autophagy inhibitors worsen the phenotype.\",\n      \"method\": \"Oligodendrocyte cell lines transfected with EIF2B3-c.1037T>C mutant or wild-type, cell viability assay, apoptosis measurement, autophagy flux measurement, autophagy inducer/inhibitor treatments\",\n      \"journal\": \"Brain & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-based KO/mutant model with pharmacological rescue and mechanistic pathway identification; single lab\",\n      \"pmids\": [\"26625702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"An intronic polyadenylation (IPA) isoform of EIF2B3 (EIF2Bγ) produces a C-terminally truncated protein that has unfavorable predicted interactions with EIF2γ, potentially decreasing stability of the nonproductive EIF2:EIF2B complex and modulating the balance between productive and nonproductive states.\",\n      \"method\": \"Transcript and protein level analyses of IPA isoform in breast cancer and normal cells, structural modeling of truncated vs. canonical EIF2Bγ–EIF2γ interaction\",\n      \"journal\": \"Proteins\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — protein interaction prediction by structural modeling, with expression-level confirmation of IPA isoform; no in vitro functional validation\",\n      \"pmids\": [\"34796993\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EIF2B3 encodes the γ-subunit of eIF-2B, a heteropentameric (α–ε) guanine nucleotide exchange factor that recycles eIF-2·GDP to eIF-2·GTP to enable repeated rounds of translation initiation; its GEF activity is inhibited when eIF-2α is phosphorylated (Ser-51) and further modulated by GSK-3-mediated phosphorylation of the ε-subunit at Ser-535, MEK/ERK signalling, glucose availability, and by the γ-subunit's pyrophosphorylase-like and β-helix domains which are essential for eIF-2B complex assembly.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"GSK-3 phosphorylates the largest (epsilon) subunit of eIF-2B and is rapidly inactivated by insulin, linking insulin signalling to eIF-2B activation through GSK-3 inhibition.\",\n      \"method\": \"Mono-S chromatography of CHO cell extracts, immunoblotting with GSK-3 isoform-specific antibodies, peptide kinase assays, protein phosphatase-2A reversal experiments\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal biochemical fractionation + immunoblotting + phosphatase reversal; replicated in subsequent studies\",\n      \"pmids\": [\"8397507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Agents that disrupt ER calcium homeostasis (thapsigargin, A23187, DTT) cause phosphorylation of eIF-2α and a ~50% reduction in eIF-2B activity, inhibiting translational initiation; chronic exposure leads to recovery coincident with eIF-2α dephosphorylation.\",\n      \"method\": \"Intact GH3 cell treatment, eIF-2B activity assay, isoelectric focusing to measure eIF-2α phosphorylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean cell-based assays with multiple agents and time-course; single lab\",\n      \"pmids\": [\"1512215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"In yeast, overexpression of all five subunits of eIF-2B suppresses eIF-2α hyperphosphorylation effects on general and GCN4-specific translation; phosphorylated eIF-2 acts as a competitive inhibitor of eIF-2B rather than forming an irreversibly inhibitory complex.\",\n      \"method\": \"Gene dosage experiments (overexpression and deletion of eIF-2B subunit genes in S. cerevisiae), GCN4-lacZ reporter assays, genetic epistasis\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple genetic manipulations and orthogonal reporter assays in yeast; strong preponderance of evidence\",\n      \"pmids\": [\"7565788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"eIF-2B is a heteropentamer (α, β, γ, δ, ε subunits) functioning as a guanine nucleotide exchange factor for eIF-2; it promotes release of GDP from eIF-2·GDP, enabling formation of active eIF-2·GTP. The ε subunit is catalytically essential, and phosphorylation of eIF-2α inhibits eIF-2B activity.\",\n      \"method\": \"Biochemical purification, guanine nucleotide exchange assays, review of cloning data and functional complementation studies\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — synthesis of multiple in vitro reconstitution and genetic studies across labs\",\n      \"pmids\": [\"7893825\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"EIF2Bγ (the gamma subunit of eIF2B) is required for HCV IRES-mediated translation; ribozymes targeting EIF2Bγ mRNA inhibit IRES-dependent translation of HCV core protein without affecting cap-dependent translation.\",\n      \"method\": \"Randomized hairpin ribozyme library selection in HeLa cells stably expressing bicistronic HCV IRES reporter, ganciclovir/hygromycin selection, functional validation with additional ribozymes\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional genomics selection with multiple ribozyme validations; single lab\",\n      \"pmids\": [\"10900014\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Glucose stimulates eIF-2B guanine nucleotide exchange activity in isolated rat islets of Langerhans within 15 min, over the same concentration range that stimulates insulin synthesis, via a mechanism independent of eIF-2α phosphorylation.\",\n      \"method\": \"eIF-2B activity assay in isolated rat islets, eIF-2α phosphorylation measured by isoelectric focusing/immunoblot, mannoheptulose as non-metabolizable control\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal assays in primary tissue; single lab\",\n      \"pmids\": [\"8567668\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Purified rat and bovine liver eIF-2B is a five-subunit complex (30.9–89.1 kDa); protein kinase activity in rat liver extracts phosphorylates only the ε subunit of eIF-2B. Quantitative immunoassay shows eIF-2B:eIF-2 ratios of ~0.6 (liver) and ~0.3 (reticulocytes).\",\n      \"method\": \"Biochemical purification to >95% homogeneity, monoclonal antibody generation, kinase assays with purified eIF-2B as substrate, quantitative immunoblotting\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical purification with in vitro kinase assay and rigorous quantitation\",\n      \"pmids\": [\"7803480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Mutations in the GCD7 (β) subunit of yeast eIF-2B overcome inhibition by phosphorylated eIF-2α without impairing catalytic GEF function, demonstrating that GCD7/eIF2Bβ plays a key role in the regulatory interaction between phospho-eIF-2 and eIF-2B.\",\n      \"method\": \"Suppressor mutation screen in S. cerevisiae, GCN4-lacZ reporter assays, growth assays under amino acid starvation and with constitutively active GCN2c kinase, expression of mammalian dsRNA-PK\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with multiple alleles and orthogonal functional tests; strong evidence\",\n      \"pmids\": [\"8164676\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Anti-ε monoclonal antibody inhibits eIF-2B guanine nucleotide exchange activity and protein synthesis at the initiation level in reticulocyte lysate; anti-β and anti-δ antibodies do not, establishing the ε subunit as essential for catalytic GEF activity.\",\n      \"method\": \"Monoclonal antibody inhibition assays of eIF-2B GEF activity and reticulocyte lysate translation, Western blotting, ELISA, immunoprecipitation\",\n      \"journal\": \"European journal of biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct inhibition of purified activity with subunit-specific antibodies; clean functional distinction\",\n      \"pmids\": [\"8168527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Phosphorylation of eIF-2α at Ser-51 by HRI kinase inhibits eIF-2B GEF activity; Ser-48 in eIF-2α maintains high affinity between phospho-eIF-2 and eIF-2B, thereby inactivating eIF-2B. Expression of 51A mutant eIF-2α protects eIF-2B from inhibition.\",\n      \"method\": \"Overexpression of wild-type and mutant eIF-2α (S48A, S51A) in CHO cells, addition of purified HRI kinase to cell extracts, eIF-2B GEF activity assays, heat-shock experiments\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro kinase assays combined with cell-based overexpression and mutagenesis; multiple conditions\",\n      \"pmids\": [\"8007958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"GSK-3 phosphorylates eIF2Bε at Ser-535 in vivo; dephosphorylation of Ser-535 alone is insufficient for insulin-mediated activation of eIF2B, indicating additional regulatory inputs are required beyond GSK-3 inactivation.\",\n      \"method\": \"Site-specific phosphorylation analysis, GSK-3 inhibitors (LiCl, SB-415286, SB-216763) in CHO cells, eIF2B activity assays, phospho-specific antibodies\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple GSK-3 inhibitors with matched phosphorylation and activity measurements; strong evidence\",\n      \"pmids\": [\"12133000\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"EGF- and NGF-induced activation of eIF2B in PC12 cells requires MEK/ERK signalling (blocked by PD98059), and this occurs without detectable dephosphorylation of the GSK-3 site Ser-535 in eIF2Bε, revealing a GSK-3-independent activation pathway.\",\n      \"method\": \"PC12 cell treatment with EGF/NGF ± MEK inhibitor PD98059, eIF2B activity assays, phospho-Ser535 immunoblotting, GSK-3 activity measurement\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibition with matched activity and phosphorylation readouts; single lab\",\n      \"pmids\": [\"10913625\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1987,\n      \"finding\": \"Phosphorylation of eIF-2α prevents eIF-2B-mediated dissociation of eIF-2·GDP from the 60S ribosomal subunit of complete initiation complexes, causing accumulation of eIF-2 on polysomes and a shift from 43S to 48S pre-initiation complexes; exogenous eIF-2B reverses these effects.\",\n      \"method\": \"Rabbit reticulocyte lysate sedimentation analysis, polysome profiling, Met-tRNA binding assays, addition of exogenous purified eIF-2B\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution with purified eIF-2B, multiple sedimentation and binding assays; mechanistically detailed\",\n      \"pmids\": [\"3646234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Sugar phosphates (glucose 6-phosphate, fructose 1,6-diphosphate) are required for eIF-2B activity by a mechanism independent of eIF-2α phosphorylation, suggesting a direct allosteric effect of sugar phosphates on eIF-2B function.\",\n      \"method\": \"Gel-filtered reticulocyte lysate translation assays, eIF-2B GDP dissociation assays, antibody neutralization of HCR kinase, isoelectric focusing for eIF-2α phosphorylation\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches in cell-free system; single lab\",\n      \"pmids\": [\"2842334\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"When eIF-2 is complexed with eIF-2B, dephosphorylation of eIF-2α is inhibited 75% and phosphorylation of eIF-2β cannot be detected, whereas Met-tRNAi·GTP ternary complex formation specifically protects eIF-2β from dephosphorylation; these results show that eIF-2B and Met-tRNAi regulate accessibility of eIF-2 phosphorylation/dephosphorylation sites.\",\n      \"method\": \"Addition of doubly phosphorylated eIF-2 to reticulocyte lysate and purified phosphatase, kinase assays on eIF-2·eIF-2B complex, ternary complex formation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro reconstitution with purified components; single lab\",\n      \"pmids\": [\"6088496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1991,\n      \"finding\": \"eIF-2B-catalyzed conversion of eIF-2·GDP to eIF-2·GTP requires Met-tRNAi(fMet) (not tRNAi alone) for efficient GDP-to-GTP exchange; without Met-tRNAi, eIF-2B can dissociate GDP but cannot efficiently drive formation of the eIF-2·GTP complex.\",\n      \"method\": \"In vitro guanine nucleotide exchange assays with purified eIF-2 and eIF-2B, [3H]GDP release assays, ternary complex reconstitution\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct in vitro reconstitution with purified components; single lab\",\n      \"pmids\": [\"1764100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"eIF-2B from calf brain is a five-subunit GEF complex (82, 65, 52, 42, 30 kDa) whose exchange activity is inhibited by N-ethylmaleimide; a 37-kDa calmodulin-binding protein co-purifies with the initiation factors from brain.\",\n      \"method\": \"Biochemical purification from brain (heparin-Sepharose, SP-5PW, DEAE-5PW HPLC), GEF activity assays, ternary complex assays, NEM inhibition\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct biochemical purification and activity characterization; single tissue/lab\",\n      \"pmids\": [\"7616232\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The pyrophosphorylase-like domains (PLDs) and left-handed β-helix (LβH) domains of eIF2Bγ and eIF2Bε mediate extensive intersubunit interactions required for eIF2Bγ–ε subcomplex formation and overall eIF2B complex assembly; a potential nucleotide-binding region in the eIF2Bε PLD does not significantly contribute to nucleotide exchange catalysis.\",\n      \"method\": \"Co-expression and co-precipitation of domain constructs in yeast, genetic interaction analysis, domain deletion series\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic domain mapping with co-precipitation and genetic approaches; single lab\",\n      \"pmids\": [\"22238343\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"The rat eIF-2Bα subunit cDNA encodes a 305 aa protein with 42% identity to yeast GCN3; it functionally complements a gcn3 deletion in yeast for GCN4-dependent gene induction, establishing GCN3 as the yeast ortholog of mammalian eIF-2Bα.\",\n      \"method\": \"cDNA cloning from rat brain library, in vitro expression, Northern blotting, functional complementation of gcn3-null yeast\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional cross-species complementation plus sequence and expression validation\",\n      \"pmids\": [\"7753796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"VWM-associated mutations in eIF2Bα cause diverse biochemical defects including loss of binding to the eIF2B complex, reduction of GEF activity, or (unexpectedly) increased GEF activity, demonstrating that eIF2Bα participates in both structural integrity and regulatory modulation of the eIF2B complex.\",\n      \"method\": \"Overexpression of mutant eIF2Bα in HEK293 cells, affinity chromatography, co-immunoprecipitation of complex subunits, GEF activity assays\",\n      \"journal\": \"BMC medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple mutations tested with co-IP and activity assays; single lab\",\n      \"pmids\": [\"26285592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"CRISPR-generated zebrafish eif2b3 loss-of-function mutants display defects in myelin development, glial cell differentiation, increased integrated stress response gene expression, and ectopic VEGF-driven angiogenesis; VEGF receptor inhibition reduces ectopic angiogenesis, providing a VWM disease model and validating 19 human EIF2B3 disease variants.\",\n      \"method\": \"CRISPR mutagenesis in zebrafish, histology/immunostaining of myelin and glia, gene expression analysis, in silico protein modeling, VEGF receptor inhibitor treatment (SU5416), validation of human variants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR knockout with multiple cellular phenotype readouts plus pharmacological rescue; strong vertebrate model\",\n      \"pmids\": [\"33517449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Oligodendrocytes transfected with mutant EIF2B3 (c.1037T>C) show decreased tolerance to ER stress, depressed autophagy flux (reduced Atg3 and Atg7 expression), and increased apoptosis; autophagy inducers restore viability, while autophagy inhibitors worsen apoptosis, placing EIF2B3 mutation in a pathway connecting ER stress to autophagic dysfunction.\",\n      \"method\": \"Oligodendrocyte transfection with EIF2B3 mutant vs. wild-type, cell viability and apoptosis assays, autophagy flux measurement, Atg gene expression analysis, autophagy modulator treatments\",\n      \"journal\": \"Brain & development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — multiple cell-based assays with pharmacological rescue; single lab\",\n      \"pmids\": [\"26625702\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"ISRIB reverses ISR attenuation by targeting an interaction between eIF2 and eIF2B; clustered missense mutations at the amino-terminal portion of the eIF2Bδ subunit (introduced by CRISPR-Cas9) reverse both ISRIB-mediated ISR inhibition and its stimulatory effect on eIF2B GEF activity in vitro.\",\n      \"method\": \"Somatic mutation screen, CRISPR-Cas9 knock-in of mutations, eIF2B GEF activity assays in vitro, ISR reporter cell assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — CRISPR knock-in mutagenesis combined with in vitro GEF activity reconstitution; replicated by structural studies\",\n      \"pmids\": [\"25858979\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Cryo-EM structure of human eIF2B at 4.1 Å resolution reveals ISRIB bound at the interface between the β and δ regulatory subunits; mutagenesis of residues lining this pocket alters ISRIB binding and the cellular ISR response, identifying a regulatory site that controls eIF2B activity.\",\n      \"method\": \"Cryo-electron microscopy (4.1 Å), site-directed mutagenesis of the ISRIB binding pocket, ISRIB binding assays in vitro, cellular ISR reporter assays\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM structure with mutagenesis validation; replicated by independent structural study\",\n      \"pmids\": [\"29599245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Atomic-resolution cryo-EM structure of human eIF2B shows it forms a decameric holoenzyme (two tetrameric subcomplexes); ISRIB binds in a deep central cleft and promotes assembly of the decamer by cross-bridging a central symmetry interface, thereby enhancing GEF activity.\",\n      \"method\": \"Cryo-electron microscopy (atomic resolution), biochemical reconstitution of decameric complex, ISRIB binding assays, assembly-state analysis\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — atomic-resolution structure with biochemical validation of assembly mechanism; independent corroboration from second cryo-EM study\",\n      \"pmids\": [\"29599213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mutations in EIF2B3 (encoding the γ subunit of eIF2B) cause leukoencephalopathy with vanishing white matter disease, demonstrating that all five eIF2B subunit genes can independently cause VWM.\",\n      \"method\": \"Mutation analysis/sequencing of EIF2B1-5 genes in VWM patients with previously unresolved genotype\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — disease-gene identification by sequencing; establishes EIF2B3 as causative for VWM\",\n      \"pmids\": [\"11835386\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"siRNA knockdown of eIF2Bγ in HCV-infected Huh7 cells inhibits HCV replication and core protein expression; combined knockdown of eIF2Bγ with IRES-specific siRNA produces stronger inhibition than either alone, confirming eIF2Bγ as an HCV co-factor in vivo.\",\n      \"method\": \"siRNA transfection in Huh7-HCV cells, fluorescence quantitative PCR, Western blotting for core protein\",\n      \"journal\": \"Zhonghua gan zang bing za zhi\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — RNAi knockdown with matched mRNA and protein readouts; single lab\",\n      \"pmids\": [\"23207339\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"EIF2B3 encodes the γ subunit of eIF2B, a heterodecameric guanine nucleotide exchange factor (GEF) for eIF2 that is essential for translation initiation; its γ and ε subunits share pyrophosphorylase-like and left-handed β-helix domains that mediate intersubunit interactions, the ε subunit carries the catalytic GEF activity and is phosphorylated/inhibited by GSK-3 at Ser-535 (activated by insulin through GSK-3 inactivation), eIF2α phosphorylation inhibits eIF2B by converting eIF2 into a competitive inhibitor that traps eIF2B in an inactive complex, ISRIB activates eIF2B by binding at the β–δ subunit interface to promote decameric holoenzyme assembly, and EIF2B3 loss-of-function mutations cause vanishing white matter disease through defective myelination, impaired stress responses, and dysregulated autophagy in oligodendrocytes.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"EIF2B3 encodes the γ-subunit of eIF-2B, a heteropentameric (α–ε) guanine nucleotide exchange factor that recycles eIF-2·GDP to eIF-2·GTP to sustain translation initiation, with its activity centrally regulated by eIF-2α phosphorylation, GSK-3/insulin signaling, MEK/ERK signaling, and glucose/sugar phosphate availability [PMID:8168527, PMID:8397507, PMID:10913625, PMID:8567668]. The γ-subunit contributes structurally to eIF-2B complex integrity through its pyrophosphorylase-like and β-helix domains rather than directly catalyzing nucleotide exchange, and disease-associated mutations in EIF2B3 disrupt complex assembly and GEF activity [PMID:22238343, PMID:26285592]. Phosphorylated eIF-2α acts as a competitive inhibitor that sequesters eIF-2B, and complex formation between eIF-2 and eIF-2B reciprocally shields phosphorylation sites from kinases and phosphatases [PMID:7565788, PMID:6088496]. Loss-of-function mutations in EIF2B3 cause vanishing white matter disease (leukoencephalopathy with vanishing white matter), characterized by impaired myelination, defective glial differentiation, activated integrated stress response, and decreased ER stress tolerance with suppressed autophagy in oligodendrocytes [PMID:33517449, PMID:26625702].\",\n  \"teleology\": [\n    {\n      \"year\": 1984,\n      \"claim\": \"Establishing that eIF-2B physically shields eIF-2 phosphorylation sites from kinases and phosphatases showed that complex formation itself is a regulatory event, not merely a catalytic intermediate.\",\n      \"evidence\": \"In vitro kinase/phosphatase accessibility assays with purified eIF-2 and eIF-2B from reticulocyte lysate\",\n      \"pmids\": [\"6088496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Only reticulocyte system tested; relevance to other cell types not assessed\", \"Stoichiometry of protective effect not determined\"]\n    },\n    {\n      \"year\": 1987,\n      \"claim\": \"Demonstrating that phospho-eIF-2α blocks eIF-2B-mediated release of eIF-2·GDP from ribosomes provided the first mechanistic link between eIF-2α phosphorylation and translational arrest at the ribosomal level.\",\n      \"evidence\": \"Sucrose gradient sedimentation of reticulocyte lysate ribosomes with exogenous eIF-2B addition\",\n      \"pmids\": [\"3646234\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which phospho-eIF-2α traps eIF-2B on ribosomes not resolved at atomic level\"]\n    },\n    {\n      \"year\": 1991,\n      \"claim\": \"Showing that Met-tRNAiMet is required for efficient eIF-2B-catalyzed GDP→GTP exchange under physiological conditions revealed that the ternary complex product stabilizes an otherwise transient eIF-2·GTP intermediate.\",\n      \"evidence\": \"In vitro nucleotide exchange assay with purified eIF-2B, eIF-2, and [³H]GDP ± Met-tRNAiMet\",\n      \"pmids\": [\"1764100\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinetic parameters not determined under cellular Mg²⁺/GTP concentrations\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Connecting ER stress to eIF-2B inhibition via eIF-2α phosphorylation established eIF-2B as a downstream effector integrating stress signals into translational control.\",\n      \"evidence\": \"Pharmacological ER stress induction (thapsigargin, DTT) in GH3 cells with eIF-2B activity and eIF-2α phosphorylation measurements\",\n      \"pmids\": [\"1512215\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the eIF-2α kinase activated by ER stress not determined in this study\", \"Recovery mechanism not fully elucidated\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identifying GSK-3 as a kinase that phosphorylates eIF-2Bε and showing insulin relieves this inhibition via GSK-3 inactivation placed eIF-2B under direct growth factor/signaling control independent of eIF-2α phosphorylation.\",\n      \"evidence\": \"Kinase fractionation, GSK-3 isoform-specific immunoblotting, and phosphatase reversal in insulin-treated CHO cells\",\n      \"pmids\": [\"8397507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation site on eIF-2Bε not mapped in this study\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Biochemical and genetic dissection established that eIF-2B is a heteropentamer whose ε-subunit provides catalytic GEF activity, while the β- and δ-subunits mediate inhibitory sensing of phospho-eIF-2α, and phospho-eIF-2 acts as a competitive inhibitor rather than forming a dead-end complex.\",\n      \"evidence\": \"Purified eIF-2B GEF assays with subunit-specific antibodies (rabbit reticulocyte); suppressor genetics in yeast; mutagenesis of eIF-2α Ser-48/Ser-51 in CHO cells\",\n      \"pmids\": [\"8168527\", \"8164676\", \"8007958\", \"7565788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise contribution of γ-subunit to regulation versus assembly not resolved at this stage\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Glucose activation of eIF-2B independent of eIF-2α phosphorylation, together with earlier evidence for sugar phosphate stimulation, revealed a metabolic input to eIF-2B distinct from stress-kinase pathways.\",\n      \"evidence\": \"eIF-2B activity assay in rat pancreatic islets across physiological glucose concentrations; reticulocyte lysate supplementation with glucose-6-phosphate\",\n      \"pmids\": [\"8567668\", \"2842334\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct molecular target of glucose/sugar phosphates on eIF-2B subunits not identified\", \"In vivo relevance outside islets not confirmed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"MEK/ERK signaling was shown to activate eIF-2B via a mechanism distinct from GSK-3/Ser535 dephosphorylation, adding a second growth-factor-responsive regulatory input; separately, eIF-2Bγ was identified as specifically required for HCV IRES-mediated translation.\",\n      \"evidence\": \"MEK inhibitor epistasis in PC12 cells with eIF-2B activity and phospho-Ser535 readouts; ribozyme library screen in HeLa cells with HCV IRES reporter\",\n      \"pmids\": [\"10913625\", \"10900014\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct target of MEK/ERK on eIF-2B subunits unknown\", \"Mechanism by which eIF-2Bγ specifically supports IRES translation not determined\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Pharmacological GSK-3 inhibition dephosphorylated eIF-2Bε Ser535 without activating eIF-2B, proving that insulin-mediated activation requires additional inputs beyond Ser535 dephosphorylation.\",\n      \"evidence\": \"Multiple GSK-3 inhibitors (LiCl, SB-415286, SB-216763) in CHO cells with phospho-Ser535 and eIF-2B activity measurements\",\n      \"pmids\": [\"12133000\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the additional insulin-responsive input(s) to eIF-2B remains unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Domain mapping of eIF-2Bγ showed its pyrophosphorylase-like and β-helix domains are essential for intersubunit contacts within the eIF-2B complex but dispensable for nucleotide exchange catalysis, clarifying the γ-subunit as a structural scaffold.\",\n      \"evidence\": \"Co-expression/co-precipitation of domain deletion constructs in yeast and mammalian cells; mutagenesis of putative nucleotide-binding residues\",\n      \"pmids\": [\"22238343\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Crystal or cryo-EM structure of eIF-2Bγ domains within the holoenzyme not yet available at this time\", \"Whether γ-subunit allosterically modulates catalysis not excluded\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"VWM disease mutations in EIF2B3 were shown to impair eIF-2B complex assembly and GEF activity (some paradoxically increasing it), and mutant oligodendrocytes displayed decreased ER stress tolerance linked to suppressed autophagy, establishing molecular and cellular pathomechanisms.\",\n      \"evidence\": \"Affinity chromatography and GEF assays of VWM-mutant eIF-2B subunits in HEK293 cells; autophagy flux and viability assays in mutant oligodendrocyte lines with pharmacological rescue\",\n      \"pmids\": [\"26285592\", \"26625702\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structural basis for divergent effects of individual VWM mutations not resolved\", \"Whether autophagy defect is primary or secondary to ISR dysregulation unclear\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CRISPR knockout of zebrafish eif2b3 recapitulated VWM-like pathology (defective myelination, impaired glial differentiation, ISR activation) and revealed ectopic angiogenesis via VEGF upregulation as a novel disease phenotype rescuable by VEGF receptor inhibition.\",\n      \"evidence\": \"CRISPR mutagenesis of zebrafish eif2b3 with myelin/glial marker staining, ISR gene expression, angiogenesis imaging, and SU5416 rescue\",\n      \"pmids\": [\"33517449\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether VEGF-driven angiogenesis occurs in human VWM patients not established\", \"Cell-autonomous versus non-autonomous effects on myelination not fully dissected\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The identity of the additional insulin-responsive input(s) to eIF-2B beyond GSK-3/Ser535, the structural basis for how individual VWM mutations in EIF2B3 differentially affect complex assembly versus catalysis, and whether the γ-subunit allosterically modulates the catalytic ε-subunit remain open mechanistic questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of human eIF-2B holoenzyme with disease mutations mapped\", \"Mechanism of glucose/sugar-phosphate activation of eIF-2B at the subunit level unknown\", \"Role of eIF-2Bγ in IRES-specific translation not mechanistically explained\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 11, 16]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [11, 16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0006413\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 12, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 8, 9]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 17, 18]}\n    ],\n    \"complexes\": [\n      \"eIF-2B\"\n    ],\n    \"partners\": [\n      \"EIF2B1\",\n      \"EIF2B2\",\n      \"EIF2B4\",\n      \"EIF2B5\",\n      \"EIF2S1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"EIF2B3 encodes the γ subunit of eIF2B, a heterodecameric guanine nucleotide exchange factor (GEF) that catalyzes GDP-to-GTP exchange on eIF2, a rate-limiting step in translation initiation [PMID:7893825, PMID:29599213]. The γ subunit contributes to holoenzyme assembly through its pyrophosphorylase-like and left-handed β-helix domains, which form extensive contacts with the catalytic ε subunit [PMID:22238343]; catalytic GEF activity resides in the ε subunit and is regulated by eIF2α phosphorylation (converting eIF2 into a competitive inhibitor of eIF2B), by GSK-3–mediated phosphorylation of ε Ser-535, and by ISRIB binding at the β–δ interface that promotes decameric assembly [PMID:7565788, PMID:8007958, PMID:25858979, PMID:29599245]. Loss-of-function mutations in EIF2B3 cause vanishing white matter disease (leukoencephalopathy), characterized by defective myelination, impaired integrated stress responses, and dysregulated autophagy in oligodendrocytes [PMID:11835386, PMID:33517449, PMID:26625702].\",\n  \"teleology\": [\n    {\n      \"year\": 1984,\n      \"claim\": \"Early reconstitution showed that eIF-2B binding shields eIF-2 phosphorylation sites, establishing that the eIF-2·eIF-2B interaction is structurally intimate enough to alter substrate accessibility for kinases and phosphatases.\",\n      \"evidence\": \"In vitro addition of purified eIF-2B to phosphorylated eIF-2 in reticulocyte lysate with kinase/phosphatase assays\",\n      \"pmids\": [\"6088496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Stoichiometry and binding interface unknown at this stage\", \"Physiological relevance of shielding not tested in cells\"]\n    },\n    {\n      \"year\": 1987,\n      \"claim\": \"Polysome profiling revealed that phospho-eIF-2α blocks eIF-2B-mediated GDP release from eIF-2 on ribosomes, trapping initiation complexes — this defined the mechanistic step at which translational inhibition occurs.\",\n      \"evidence\": \"Sedimentation analysis and Met-tRNA binding assays in reticulocyte lysate with purified eIF-2B add-back\",\n      \"pmids\": [\"3646234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity and contribution of individual eIF-2B subunits not resolved\", \"No structural information on the eIF-2·eIF-2B interface\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"ER-stress agents were shown to inhibit eIF-2B activity via eIF-2α phosphorylation, extending the regulatory paradigm from heme deficiency to a broader integrated stress response.\",\n      \"evidence\": \"Thapsigargin/A23187/DTT treatment of GH3 cells with eIF-2B activity and eIF-2α phosphorylation measurements\",\n      \"pmids\": [\"1512215\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Kinase identity mediating ER-stress-induced eIF-2α phosphorylation not identified\", \"Mechanism of chronic recovery unclear\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Identification of GSK-3 as the kinase phosphorylating the ε subunit of eIF-2B linked insulin signalling to translational control: insulin inactivates GSK-3, relieving inhibitory phosphorylation of eIF-2Bε.\",\n      \"evidence\": \"Mono-S chromatography fractionation of CHO extracts, GSK-3 isoform-specific immunoblotting, phosphatase-2A reversal\",\n      \"pmids\": [\"8397507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GSK-3 target site on ε not yet mapped\", \"Whether GSK-3 inhibition alone is sufficient for full activation unknown\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Biochemical purification established eIF-2B as a five-subunit (α–ε) GEF, and antibody inhibition experiments demonstrated that the ε subunit is the catalytically essential GEF subunit, while β and δ are dispensable for catalysis per se.\",\n      \"evidence\": \"Purification to homogeneity from liver, subunit-specific monoclonal antibody inhibition of GEF activity and reticulocyte lysate translation\",\n      \"pmids\": [\"7803480\", \"8168527\", \"7893825\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functions of non-catalytic subunits (including γ) not defined\", \"No atomic structure\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Yeast genetics showed that eIF2Bβ mutations uncouple phospho-eIF-2 sensing from catalytic function, establishing the regulatory subcompllex (α/β/δ) as a distinct functional module sensing eIF-2α phosphorylation.\",\n      \"evidence\": \"GCD7 suppressor mutations in S. cerevisiae with GCN4-lacZ reporter and mammalian kinase expression\",\n      \"pmids\": [\"8164676\", \"8007958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular contacts between phospho-eIF-2α and the regulatory subcomplex unresolved\", \"Role of γ subunit in regulation unclear\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Overexpression of all five eIF-2B subunits in yeast demonstrated that phospho-eIF-2 acts as a competitive inhibitor rather than forming an irreversibly trapped complex, resolving a long-standing mechanistic debate.\",\n      \"evidence\": \"Gene dosage manipulation in S. cerevisiae with GCN4-lacZ reporters and genetic epistasis\",\n      \"pmids\": [\"7565788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative binding parameters for phospho- vs. non-phospho-eIF-2 not determined\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"EIF2B3 (γ subunit) was identified as specifically required for HCV IRES-mediated translation but not cap-dependent translation, revealing a subunit-specific role beyond general GEF function.\",\n      \"evidence\": \"Randomized ribozyme library screen in HeLa cells with bicistronic HCV IRES reporter\",\n      \"pmids\": [\"10900014\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which γ depletion selectively affects IRES translation not elucidated\", \"Confirmed only with ribozymes in one cell line\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Two parallel advances: (1) GSK-3 phosphorylation of eIF2Bε was mapped to Ser-535, but dephosphorylation alone was shown insufficient for insulin-mediated activation, revealing additional regulatory inputs; (2) EIF2B3 mutations were found to cause vanishing white matter disease, establishing the γ subunit as independently disease-causative.\",\n      \"evidence\": \"GSK-3 inhibitors in CHO cells with phospho-specific antibodies; sequencing of EIF2B genes in VWM patients\",\n      \"pmids\": [\"12133000\", \"11835386\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the additional insulin-responsive input unknown\", \"Genotype–phenotype correlations for EIF2B3 mutations incomplete\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Domain mapping showed that the pyrophosphorylase-like and left-handed β-helix domains of the γ and ε subunits mediate their association, defining the structural basis for the γ–ε subcomplex within the holoenzyme.\",\n      \"evidence\": \"Co-expression/co-precipitation of domain constructs in yeast with domain deletion series\",\n      \"pmids\": [\"22238343\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No atomic-resolution structure of the γ–ε interface\", \"Functional consequences of disrupting specific domain contacts not fully tested in mammalian cells\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"ISRIB was shown to act by enhancing eIF2B GEF activity through a site on the β/δ regulatory subunits, and VWM-associated mutations in eIF2Bα and EIF2B3 were shown to impair ER stress tolerance and autophagy in oligodendrocytes, connecting eIF2B dysfunction to glial pathology.\",\n      \"evidence\": \"CRISPR knock-in mutagenesis with in vitro GEF assays for ISRIB; oligodendrocyte transfection with EIF2B3 mutant plus autophagy flux measurements\",\n      \"pmids\": [\"25858979\", \"26625702\", \"26285592\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of ISRIB binding not yet resolved\", \"Whether autophagy rescue is therapeutically relevant in vivo untested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Cryo-EM structures of the eIF2B decamer revealed that ISRIB binds a deep cleft at the β–δ symmetry interface and promotes decameric assembly, providing the atomic-level explanation for ISRIB pharmacology and illuminating the architecture of the holoenzyme including the γ subunit position.\",\n      \"evidence\": \"Cryo-EM at 4.1 Å and atomic resolution from two independent groups, with mutagenesis validation\",\n      \"pmids\": [\"29599245\", \"29599213\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure of the eIF2B–eIF2 complex not resolved at this point\", \"Conformational dynamics of substrate engagement by γ–ε catalytic lobe unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"CRISPR-generated zebrafish eif2b3 knockouts recapitulated VWM hallmarks — myelin defects, glial differentiation failure, ISR activation, and ectopic VEGF-driven angiogenesis — and VEGF inhibition partially rescued the vascular phenotype, identifying a potential therapeutic axis.\",\n      \"evidence\": \"CRISPR mutagenesis in zebrafish with histology, gene expression profiling, and SU5416 pharmacological rescue\",\n      \"pmids\": [\"33517449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether VEGF dysregulation is a direct or indirect consequence of eIF2B3 loss unknown\", \"Translatability of VEGF inhibition to mammalian VWM models not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the specific structural contribution of the γ subunit to phospho-eIF2 sensing and GEF catalysis, the mechanism by which γ-subunit mutations selectively impair oligodendrocyte function, and whether γ-specific therapeutic strategies can complement ISRIB-like approaches for VWM.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of eIF2B–phospho-eIF2 complex with γ contacts mapped\", \"Cell-type-specific vulnerability of oligodendrocytes to EIF2B3 mutations mechanistically unexplained\", \"No therapeutic rescue of EIF2B3-specific mutations demonstrated in mammalian disease models\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [3, 8, 17, 22, 24]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 12, 15, 24]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 10, 11]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [1, 9, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [20, 25]}\n    ],\n    \"complexes\": [\n      \"eIF2B\"\n    ],\n    \"partners\": [\n      \"EIF2B5\",\n      \"EIF2B2\",\n      \"EIF2B4\",\n      \"EIF2B1\",\n      \"EIF2S1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}